Market Tracker

04/27 6:01pm ET

Trovagene Inc (NASDAQ:TROV)

8.27
Delayed Data
As of 3:59pm ET
 -0.53 / -6.02%
Today’s Change
2.97
Today|||52-Week Range
9.18
+92.33%
Year-to-Date

Today’s Trading

Previous close8.80
Today’s open8.85
Day’s range8.13 - 9.13
Volume611,308
Average volume (3 months)359,384
Market cap$214.5M
Dividend yield--
Data as of 3:59pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-28.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales290.13
Price/Book19.94

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.20+2.08%
CALACalithera Bioscience...-1.87-13.94%
TRILTrillium Therapeutic...-2.07-8.55%
QTNTQuotient Ltd0.000.00%
Data as of 4:00pm ET, 04/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts